10 High Growth European Stocks To Buy

Page 2 of 10

9. BeOne Medicines Ltd. (NASDAQ:ONC)

5-Year Revenue Growth Rate: 54.79%

Number of Hedge Fund Holders: 21

BeOne Medicines Ltd. (NASDAQ:ONC) ranks among the best high growth European stocks to buy. On January 7, Citizens reaffirmed its Market Outperform rating and $396 price target for BeOne Medicines Ltd. (NASDAQ:ONC), citing strong effectiveness results from a Phase 3 trial in gastric cancer patients. BeOne Medicines Ltd. (NASDAQ:ONC) and Jazz Pharmaceutics shared further findings from the HERIZON-GEA-01 trial, which revealed high efficacy in patients with advanced gastric or gastroesophageal adenocarcinoma (GEA).

Citizens observed that BeOne’s Brukinsa was on track to generate about $3.8 billion in revenue in 2025, thanks to an impressive development pipeline that includes numerous assets across diverse indications.

The company also revealed the first clearance for sonrotoclax, its next-generation BCL2 inhibitor, which Citizens anticipates could contribute to subsequent approvals worldwide.

At the same time, the firm emphasized BeOne’s $4.1 billion cash position and stated that the recent share price decline represented a “unique buying opportunity” in one of the world’s leading hematology/oncology companies.

BeOne Medicines Ltd. (NASDAQ:ONC) is a global biotechnology company that specializes in oncology medicines, particularly for blood cancers and solid tumors.

Page 2 of 10